Business Models and Strategy


Interview: Dr Peter Byloos, Optegra

As HBI reported last week, UK, Czechia and Poland-based ophthalmology platform Optegra Eye Health Care is being acquired by H2 Equity Partners. HBI caught up with Optegra CEO Dr Peter Byloos to hear his views on the market (and inevitably these days, the impact of COVID), and to find out about Optegra’s plans under new ownership. 

Operators in Russia and ex-CIS hit hard by COVID

State financing has seen little growth in expenditure in Russia over the last couple of years, while former CIS countries are struggling to fund robust healthcare systems. Despite this, panellists at HBI's Russia and Former CIS - State of the Regions discussion last week found some reasons to be positive.

Interview: Javier Román, CEO, Clece

Clece is one of Spain's largest homecare providers and is also present in the UK, with total domiciliary care sales of over €400m in 2019. HBI gets a snapshot of the business and its views on sector challenges from CEO Javier Román.

Dentex gets cash injection from shareholder

In what has been a tough year for dentists across Europe, UK dental partnership group Dentex has raised a further £20m from its major shareholder "to continue success in the corporate dental world". HBI speaks to CEO Barry Lanesman to find out more.

Interview: Massimiliano Colella, CEO, Evercare Group

We talk to the CEO of Evercare Group, the diverse conglomerate of South Asia and African hospitals that make up the $1bn Evercare Health Fund originally raised by Abraaj before TPG's takeover in 2019. Colella talks strategic priorities including 'turning Evercare from a fund into a real company', recent management departures, the platform today and why his own lack of emerging market healthcare service experience doesn't matter for this job.

Analysis: which listed care providers are recovering best?

Why are listed Nordic care providers' share prices seeing a faster recovery than other European counter parts? And how has each operator weathered the storm? HBI takes a deep dive into the financials to deliver an exclusive analysis as providers prepare their Q3 results.

Addiction treatment for the mass market

UK Addiction Treatment claims 97% occupancy within a week of opening its latest facility. But would you invest in a business run by addicts for addicts? Or whose majority investor, Global Group, has recently seen its founder, Greg Lindbergh, jailed for bribing a US official? We talk to UKAT CEO, Eytan Alexander.

Diversification helps Grupo 5 grow despite COVID

Grupo 5 has carved out an unusual but successful niche for itself in Spain, balancing a mix of healthcare services (predominantly mental health and treatment for patients with brain injuries) with social emergency care for the homeless, children, and people with disability. CEO Guillermo Bell tells HBI it has proved to be a robust combination during the COVID crisis.

Find Us